Abstract:Fibrosis is one of the most important characteristics of cardiac remodeling during heart failure. The accumulation of extracellular matrix (ECM) within myocardium is the major feature of cardiac fibrosis. microRNA (miR)-19b, a key functional member of miR-19-72 cluster family, has been suggested to be involved in aging-induced heart failure through regulating ECM-related proteins, such as connective tissue growth factor (CTGF), thrombospondin-1 (TSP-1), collagen-1A1, and collagen-3A1. In the current study, we aimed to investigate the role of miR-19b in cardiac fibroblast function and ECM production using neonatal rat cardiac fibroblasts in primary culture. We found that overexpression of miR-19b increased, while inhibition of miR-19b decreased the proliferation and migration of cardiac fibroblasts, using Cell Counting Kit-8 (CCK-8) (0.660±0.019 vs 0.720±0.014 in nc-mimic and miR-19b mimic, 0.506±0.009 vs 0.454±0.008 in nc-inhibitor and miR-19b inhibitor, respectively), EdU incorporation assay (0.059±0.002 vs 0.096±0.006 in nc-mimic and miR-19b mimic, 0.059±0.006 vs 0.040±0.003 in nc-inhibitor and miR-19b inhibitor, respectively), and wound healing assay (0.528±0.024 vs 0.896±0.027 in nc-mimic and miR-19b mimic,0.520±0.028 vs 0.174±0.019 in nc-inhibitor and miR-19b inhibitor, respectively), respectively. Meanwhile, the inhibition of miR-19b downregulated the mRNA levels of α-SMA (0.556±0.048 vs 1.038±0.137 in nc-inhibitor and miR-19b inhibitor, respectively) and collagen-1 (1.023±0.116 vs 0.551±0.033 in nc-inhibitor and miR-19b inhibitor, respectively) in cardiac fibroblasts, indicating a reduction in fibroblast activation and ECM production via miR-19b inhibition. Furthermore, we found that PTEN was negatively regulated by miR-19b in cardiac fibroblasts using western blot analysis. PTEN, a well-known tumor-suppressor gene, has been known to inhibit cell proliferation and migration. However, it remains to be further clarified whether PTEN could mediate the effect of miR-19b in the proliferation, migration and activation of fibroblasts. These data might provide important evidence suggesting that miR-19b could be a potential therapeutic target for cardiac fibrosis.

Matrix metalloproteinase-9 induces cardiac fibroblast migration, collagen and cytokine secretion: Inhibition by salvianolic acid B from Salvia miltiorrhiza

Salvianolic Acid A, A Novel Matrix Metalloproteinase-9 Inhibitor, Prevents Cardiac Remodeling In Spontaneously Hypertensive Rats

[Interleukin-1Beta Upregulates Matrix Metalloproteinase-2 Expression and Activity in Cardiac Fibroblasts Via Nitric Oxide Synthase Pathway].

Matrix Metalloproteinases and Their Effects in Myocardial Fibrosis

The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms

Effects of Mesenchymal Stem Cells on Matrix Metalloproteinase Synthesis in Cardiac Fibroblasts

Matrix Metalloproteinase 3 Regulates Angiotensin II‑induced Myocardial Fibrosis Cell Viability, Migration and Apoptosis.

Salvianolic Acid A Attenuates Angiotensin Ii-Induced Cardiac Fibrosis Through Regulating The Txnip Signaling Pathway

Abstract 15392: Exosomal Microrna 486-5P Mediates Cardiac Angiogenesis Post Myocardial Infarction by Targeting MMP19 in Fibroblasts

EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling

Study on the Mechanism of Anti-myocardial Fibrosis of Salvianolic Acid B

Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling

Cardiac Fibrosis: New Insights into the Pathogenesis

Abstract 15699: Matrix Metalloproteinase-9 Overexpression in Macrophages Improves Ventricular Function by Regulating the Inflammatory and Fibrotic Responses Post-Myocardial Infarction

Abstract 370: MicroRNA-19b Contributes to Cardiac Fibrosis

Mir-19B Controls Cardiac Fibroblast Proliferation and Migration.

Targeting S100A9 Prevents β-Adrenergic Activation–Induced Cardiac Injury

Extracellular matrix remodeling and cardiac fibrosis

Effects of HMGB1 on MMP-9 Expression in Rat Cardiac Fibroblasts

Mir-145 Attenuates Cardiac Fibrosis Through the AKT/GSK-3/-catenin Signaling Pathway by Directly Targeting SOX9 in Fibroblasts

MicroRNA-19a-3p augments TGF-β1-induced cardiac fibroblast activation via targeting BAMBI